pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
TARGET
save

CD19

B-cell surface marker; CAR-T and bispecific target.

also known as: b-lymphocyte antigen cd19

🐶 often sniffed alongside

top 6
  • tagOncology3 co-mentions · 1 sources
  • tagCLL2 co-mentions · 1 sources
  • tagDLBCL1 co-mentions · 1 sources
  • tagCD201 co-mentions · 1 sources
  • tagCD221 co-mentions · 1 sources
  • drugAnti-CD19/CD20/CD22 CAR T-cells1 co-mentions · 1 sources
drugs
0
catalysts
0
news
96
companies
0

Top drugs

no drugs tagged with this interest yet

🐶 Top companies

no companies tagged with this interest yet

Recent catalysts

no catalysts tagged with this interest yet

Recent news

view all →
  • nChroma halves workforce, BioXcel lets execs go↗
    biospace · 6h ago
  • Deaths, failed trials and other recent setbacks in the autoimmune space↗
    biospace · 3d ago
  • Kyverna abandons next-gen autoimmune CAR-T once touted as follow-up to miv-cel↗
    fiercebiotech · 7d ago
  • Biopharma layoffs rise YOY in October but sharply trend down for 2026↗
    biospace · 7d ago
  • Gilead reveals partial clinical hold on 2 CAR-T cell therapy trials↗
    fiercebiotech · 21d ago
  • Artiva lays off 94% of staff after deaths and durability sink autoimmune cell therapy↗
    fiercebiotech · 23d ago
  • Novartis CEO keeps faith in Avidity deal despite taking $1.9B hit from del-desiran fail↗
    fiercebiotech · 23d ago
  • BMS sheds light on patient death in CAR-T trial, wants to get program back on track↗
    fiercebiotech · 27d ago
Data sources
openFDA · ClinicalTrials.gov · pharmadog Linker
last refreshed 2h ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?